Glaxo Group Limited

Mark Patrick Healy

Gerard Martin Paul Giblin

Helen Susanne Price

Christopher Norbert Johnson

Steven James Stanway

Neil Derek Miller

Susan Roomans

Alessandra Gaiba

Martin Edward Swarbrick

Nicholas Maughan Clayton

Andrew Billinton

A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R, R, R, R, R, m, n and X are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.

[object Object]

A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, RRR, R, R, R, X and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.

A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R, R, R, X and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.

Benzoisoindole derivatives for the treatment of pain

The present invention relates to naphthalene derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine.

Benzo [F] isoindoles as EP4 receptor agonists

A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein Rto R, X, and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.

Growing community of inventors

Harlow, United Kingdom

Mark Patrick Healy